🔎 Trials Near Me

Utama › Keletihan › Washington

Kajian klinikal Keletihan di Washington

6 kajian untuk Keletihan sedang mencari peserta di lokasi di Washington.

Bandar di Washington

Teks kajian rasmi (Bahasa Inggeris)

Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden

  • Arthritis Northwest PLLC, Spokane
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07621809

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

  • Virginia Mason Medical Center, Seattle
  • Fred Hutchinson Cancer Center, Seattle
  • University of Washington Medical Center, Seattle
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06989437

A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)

  • Washington State University Sleep and Performance Center, Spokane
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT07500090

A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy

  • Sleep and Performance Research Center, Spokane
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Ogo 2026 · NCT07675135

Factorial Optimization Trial to Test Cognitive Behavioral Therapy Components for Multiple Sclerosis Fatigue

  • Multiple Sclerosis Center at UW Medical Center - Northwest, Seattle
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Mac 2026 · NCT06809192

Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus

  • Seattle Children's Hospital, Seattle
Mengambil peserta
Umur 12 hingga 22 · Semua jantina · Dikemas kini 30 Okt 2025 · NCT06232304

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.